You are here: Industry Insights > prices

News List

Two drug firms admit to colluding to keep prices up europeanpharmaceuticalreview
September 25, 2019
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
Prices of knee implants not to increase beyond 10 per cent in a year expresspharma
August 15, 2019
The ceiling price of orthopaedic knee implants to be monitored such that the price increase of knee implants does not increase beyond 10 per cent in a given year.
Brand-Brand Competition Has Not Cut Prices in Pharma Market drugs
August 05, 2019
Brand-brand competition in the U.S. pharmaceutical market has not lowered drug list prices, according to a review published online in PLOS Medicine.
Ontario and Quebec against plan to lower Canadian drug prices europeanpharmaceuticalreview
August 02, 2019
The two Canadian provinces have expressed concern over the new draft regulations, claiming that the reforms would delay patient access to medicines.
Would Trump's new drug-imports plan do much to prices—or to pharma? fiercepharma
August 01, 2019
Discussing the pharma potshots after Tuesday night's Democratic debate, Maris said that "this follows our thesis that overall, things are getting tougher, not easier for the industry as both Trump and Biden want to make pricing tougher."
AstraZeneca and Novartis set to lose out from US drug prices reforms europeanpharmaceuticalreview
July 31, 2019
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
Bipartisan bill revealed to lower drug prices in US europeanpharmaceuticalreview
July 25, 2019
The Senate Finance Committee has unveiled its bipartisan bill in an effort to lower drug prices, requiring drug manufacturers to justify price increases.
Private Insurers Pay 241 Percent of What Medicare Would Pay drugs
May 20, 2019
Private Insurers Pay 241 Percent of What Medicare Would Pay.
Seven Indian pharma companies among the 20 sued by the US expressbpd
May 15, 2019
Seven Indian companies have been dragged in a lawsuit filed by over 40 US states for allegedly conspiring to raise the prices of drugs in the US.
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say nytimes
May 13, 2019
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on Friday by 44 states.

Previous page 1 2 3 Next page